Interestingly, HER2-specific peptide vaccination reduced ALDH positive breast cancer associated TISCs in MMTV-PyMT murine transgenic breast cancer models, suggesting a potential immunotherapeutic treatment strategy against treatment resistant TISCs (73). Here, LDHA is linked to breast carcinoma.